Pharmacogenetic Aspects of Antipsychotic Drug-induced Weight Gain - A Critical Review
Open Access
- 28 August 2012
- journal article
- Published by Korean College of Neuropsychopharmacology in Clinical Psychopharmacology and Neuroscience
- Vol. 10 (2) , 71-77
Abstract
Reynolds GP. Clin Psychopharmacol Neurosci. 2012 Aug;10(2):71-77. http://dx.doi.org/10.9758/cpn.2012.10.2.71Keywords
This publication has 48 references indexed in Scilit:
- Association of genetic variants of the histamine H1 and muscarinic M3 receptors with BMI and HbA1c values in patients on antipsychotic medicationPsychopharmacology, 2011
- Association of Allelic Variation in Genes Mediating Aspects of Energy Homeostasis with Weight Gain during Administration of Antipsychotic Drugs (CATIE Study)Frontiers in Genetics, 2011
- DRD2 promoter region variation predicts antipsychotic-induced weight gain in first episode schizophreniaPharmacogenetics and Genomics, 2010
- Association study of polymorphisms in Insulin Induced Gene 2 (INSIG2) with antipsychotic‐induced weight gain in European and African‐American schizophrenia patientsHuman Psychopharmacology: Clinical and Experimental, 2010
- Genomewide pharmacogenomic study of metabolic side effects to antipsychotic drugsMolecular Psychiatry, 2010
- A Common Polymorphism in the Cannabinoid Receptor 1 (CNR1) Gene is Associated with Antipsychotic-Induced Weight Gain in SchizophreniaNeuropsychopharmacology, 2010
- Body weight gain induced by atypical antipsychotics: an extension of the monocygotic twin and sib pair studyJournal of Clinical Pharmacy and Therapeutics, 2009
- The impact of pharmacogenetics on the development and use of antipsychotic drugsDrug Discovery Today, 2007
- P.3.003 Association between clozapine-induced weight gain and serotonin 5-HT2C receptor gene polymorphism in Korean schizophrenic patientsEuropean Neuropsychopharmacology, 2005
- Second-Generation (Atypical) Antipsychotics and Metabolic EffectsCNS Drugs, 2005